IE44603B1 - 2-phenyl-5-(5-tetrazolyl)-pyrimidin-4(3h)-one derivatives - Google Patents

2-phenyl-5-(5-tetrazolyl)-pyrimidin-4(3h)-one derivatives

Info

Publication number
IE44603B1
IE44603B1 IE297/77A IE29777A IE44603B1 IE 44603 B1 IE44603 B1 IE 44603B1 IE 297/77 A IE297/77 A IE 297/77A IE 29777 A IE29777 A IE 29777A IE 44603 B1 IE44603 B1 IE 44603B1
Authority
IE
Ireland
Prior art keywords
mixture
group
compound
oxo
dihydro
Prior art date
Application number
IE297/77A
Other languages
English (en)
Other versions
IE44603L (en
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/748,851 external-priority patent/US4082751A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IE44603L publication Critical patent/IE44603L/xx
Publication of IE44603B1 publication Critical patent/IE44603B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IE297/77A 1976-02-13 1977-02-11 2-phenyl-5-(5-tetrazolyl)-pyrimidin-4(3h)-one derivatives IE44603B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65778776A 1976-02-13 1976-02-13
US05/748,851 US4082751A (en) 1976-02-13 1976-12-08 Therapeutic agents

Publications (2)

Publication Number Publication Date
IE44603L IE44603L (en) 1977-08-13
IE44603B1 true IE44603B1 (en) 1982-01-27

Family

ID=27097492

Family Applications (1)

Application Number Title Priority Date Filing Date
IE297/77A IE44603B1 (en) 1976-02-13 1977-02-11 2-phenyl-5-(5-tetrazolyl)-pyrimidin-4(3h)-one derivatives

Country Status (14)

Country Link
JP (1) JPS52118481A (enrdf_load_stackoverflow)
AU (1) AU508970B2 (enrdf_load_stackoverflow)
CA (1) CA1083152A (enrdf_load_stackoverflow)
CH (1) CH635339A5 (enrdf_load_stackoverflow)
DE (1) DE2705609A1 (enrdf_load_stackoverflow)
DK (1) DK149044C (enrdf_load_stackoverflow)
FI (1) FI62533C (enrdf_load_stackoverflow)
FR (1) FR2340943A1 (enrdf_load_stackoverflow)
GB (1) GB1541351A (enrdf_load_stackoverflow)
IE (1) IE44603B1 (enrdf_load_stackoverflow)
LU (1) LU76722A1 (enrdf_load_stackoverflow)
NL (1) NL173055C (enrdf_load_stackoverflow)
SE (1) SE433494B (enrdf_load_stackoverflow)
YU (1) YU41567B (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
CN101747282A (zh) * 2008-12-10 2010-06-23 上海特化医药科技有限公司 一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883653A (en) * 1972-10-24 1975-05-13 Pfizer Method of preventing asthmatic symptoms

Also Published As

Publication number Publication date
JPS6139947B2 (enrdf_load_stackoverflow) 1986-09-06
SE433494B (sv) 1984-05-28
FI62533C (fi) 1983-01-10
IE44603L (en) 1977-08-13
LU76722A1 (enrdf_load_stackoverflow) 1977-08-18
CA1083152A (en) 1980-08-05
GB1541351A (en) 1979-02-28
NL7701483A (nl) 1977-08-16
FR2340943B1 (enrdf_load_stackoverflow) 1981-01-09
DE2705609A1 (de) 1977-08-25
AU508970B2 (en) 1980-04-17
NL173055B (nl) 1983-07-01
DK149044C (da) 1986-06-02
CH635339A5 (en) 1983-03-31
DE2705609C2 (enrdf_load_stackoverflow) 1988-12-15
FR2340943A1 (fr) 1977-09-09
SE7701552L (sv) 1977-09-23
YU35477A (en) 1982-10-31
DK57377A (da) 1977-08-14
JPS52118481A (en) 1977-10-04
YU41567B (en) 1987-10-31
NL173055C (nl) 1983-12-01
AU2189577A (en) 1978-08-10
FI62533B (fi) 1982-09-30
DK149044B (da) 1985-12-30
FI770427A7 (enrdf_load_stackoverflow) 1977-08-14

Similar Documents

Publication Publication Date Title
CA1098520A (en) Optionally substituted 3-(1h-tetrazol-5-yl)-4h- pyrido¬1,2-a| pyrimidin-4-ones
US3883653A (en) Method of preventing asthmatic symptoms
US4829058A (en) Substituted bis-(4-aminophenyl)-sulfones
JPH09301958A (ja) 新規ピリミジン化合物及び抗ロタウイルス剤
US4082751A (en) Therapeutic agents
FI61688C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara oxminsyraderivat
US4031093A (en) 1,6-Dihydro-6-oxo-2-(ortho-substituted phenyl)pyrimidine-5-carboxylic acid derivatives
IE44603B1 (en) 2-phenyl-5-(5-tetrazolyl)-pyrimidin-4(3h)-one derivatives
EP0244201B1 (en) 3-hydroxypyridines
JPS6160072B2 (enrdf_load_stackoverflow)
CA1117112A (en) Pyrido¬1,2-a|pyrimidine-3-n-(1h-tetrazol-5-yl| carboxamide derivatives
US3968213A (en) Method of preventing asthmatic symptoms
US3927214A (en) Method of preventing asthmatic symptoms
US3957784A (en) Bis(4-[4'-hydroxy-5'-carboxy-2'-pyrimidinyl]phenoxy)alkanes
US4096153A (en) Arylene-bis-tetrazole-5-carboxamides
EP0064385B1 (en) 2,6-diaryl-pyridinecarboxylic acids and their therapeutic utility
US3927215A (en) Method of preventing asthmatic symptoms
US3974161A (en) Fused pyrimidin-4(3H)-ones as antiallergy agents
EP0050977B1 (en) Carboxamide compounds as srs-a antagonists and a process for producing same
US3917835A (en) A method of preventing asthmatic symptoms
JPH08134044A (ja) 新規ピリミジン化合物、中間体及びそれらの製造法
US4254126A (en) 4-Carbethoxy-carbonilamino-pyrimidines and a process for their preparation
US4330555A (en) Indanyloxamic derivatives, their preparation and pharmaceutical compositions containing them
EP0047119B1 (en) Carboxamide compounds as srs-a antagonists, pharmaceutical compositions containing them, processes for the preparation, and intermediates useful therein
KR800001139B1 (ko) N-(5-테트라졸릴)-4-옥소-4H-피리미도[2,1-b]벤조티아졸류의 제조방법